… Heparin-induced thrombocytopenia (HIT) remains one of the most important complications,
and clinicians must remain vigilant to the development of this adverse event. HIT is … HIT with …

… heparin induced thrombocytopenia (HIT) where HIT antibodies develop upon heparin exposure,
and heparin induced thrombocytopenia with … The risk of developing HIT antibodies upon …

… HIT but without proximate heparin exposure); and fondaparinux-associated HIT (four distinct
syndromes featuring thrombocytopenia that … presented with ongoing thrombocytopenia (and …

… of HIT rests on demonstrating thrombocytopenia and/or … excluding other causes of
thrombocytopenia. Such an exercise is … With unusual presentations of HIT, such as …

… This chapter will address the clinical presentation of HIT and summarize recent findings
on … , while thrombotic thrombocytopenic purpura and heparin-induced thrombocytopenia (HIT) …

… Nevertheless, as seen with serum obtained from patients with otherwise typical heparin‐induced
thrombocytopenia (HIT), serum‐induced platelet activation is inhibited at high heparin …

… Positive control can be KKO or another HIT-like monoclonal antibody. Δ, delta (change);
HIT, heparin-induced thrombocytopenia; HIT Abs, HIT antibodies; IgGAM, antibodies of any of …

… nonhemorrhagic complication, heparin induced thrombocytopenia (HIT). HIT is an immune
… of HIT. We will review recent developments in our understanding of the pathogenesis of …

… Heparin-induced thrombocytopenia (HIT) is a rare, iatrogenic disease characterised by its
potential severity, mainly related to thrombosis, and by difficulties regarding its diagnosis and …

… , and heparin-induced thrombocytopenia (HIT) which is considered to be the most severe
nonbleeding adverse reaction and one of the most important adverse drug reactions [6-8]. …